Many people know Johnson & Johnson (NYSE: JNJ) for its consumer products, but the healthcare giant’s pharmaceutical business has become the most important component of its long-term growth strategy. Combined with its medical device business, Johnson & Johnson serves the entire healthcare sector, and investors have been pleased at the progress that the company has made over time.